Quick Answer
Sarepta Therapeutics, Inc. reported Earnings Per Share Diluted of $7.13 (loss) per share for the year ending 2025.
- Sarepta Therapeutics, Inc. showed a decrease of -404.7% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Sarepta Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 2, 2026.
- XBRL data for this metric is available from 2009 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2009 to 2025), Sarepta Therapeutics, Inc.'s Earnings Per Share Diluted has declined by 2,540.7%.
- Historical annual values: Fiscal year 2025: $7.13 (loss) per share | Fiscal year 2024: $2.34 per share | Fiscal year 2023: $5.80 (loss) per share | Fiscal year 2022: $8.03 (loss) per share | Fiscal year 2021: $5.15 (loss) per share | Fiscal year 2020: $7.11 (loss) per share | Fiscal year 2011: $0.02 (loss) per share | Fiscal year 2010: $0.29 (loss) per share | Fiscal year 2009: $0.27 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: